BetterLife Pharma Inc. (BETRF)

OTCMKTS · Delayed Price · Currency is USD

0.2300

-0.0700 (-23.33%)

Aug 10, 2026, 3:12 PM EST

BetterLife Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is February - January.

Millions USD. Fiscal year is Feb - Jan.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 10, 2026	Jan '26 Jan 31, 2026	Jan '25 Jan 31, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022
Market Capitalization	49	6	11	6	10	14
Market Cap Growth	307.98%	-49.81%	77.29%	-35.21%	-26.56%	-75.00%
Enterprise Value	52	9	15	8	13	12
Last Close Price	0.30	0.04	0.09	0.06	0.11	0.16

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 10, 2026	Jan '26 Jan 31, 2026	Jan '25 Jan 31, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022
PB Ratio	-10.27	-1.21	-2.26	-1.13	-1.77	-4.47

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 10, 2026	Jan '26 Jan 31, 2026	Jan '25 Jan 31, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022
Debt / Equity Ratio	-0.15	-0.14	-0.18	-0.07	-0.02	-0.08
Net Debt / Equity Ratio	-0.14	-0.14	-0.18	-0.07	-0.02	-0.04
Net Debt / EBITDA Ratio	-	-	-	-0.16	-0.02	-0.01
Net Debt / FCF Ratio	-1.09	-1.43	-0.65	-0.21	-0.12	-0.01
Quick Ratio	0.01	0.00	0.00	0.01	0.00	0.12
Current Ratio	0.04	0.03	0.03	0.04	0.01	0.28
Return on Assets (ROA)	-500.55%	-508.19%	-1074.42%	-1004.42%	-936.16%	-493.00%
Return on Capital Employed (ROCE)	29.60%	28.00%	64.60%	45.70%	130.90%	334.40%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 10, 2026	Jan '26 Jan 31, 2026	Jan '25 Jan 31, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022
Earnings Yield	-2.86%	-19.10%	-21.15%	-33.29%	-67.53%	-70.08%
FCF Yield	-1.26%	-7.99%	-12.15%	-28.49%	-11.26%	-64.57%
Buyback Yield / Dilution	-19.26%	-17.77%	-13.34%	-26.25%	-14.70%	-179.24%